- Home
- PBYI vs REKR Comparison
PBYI vs REKR Comparison
Compare PBYI & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- REKR
- Stock Information
- Founded
- PBYI 2010
- REKR 2017
- Country
- PBYI United States
- REKR United States
- Employees
- PBYI N/A
- REKR N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- REKR Telecommunications Equipment
- Sector
- PBYI Health Care
- REKR Telecommunications
- Exchange
- PBYI Nasdaq
- REKR Nasdaq
- Market Cap
- PBYI 138.4M
- REKR 115.1M
- IPO Year
- PBYI N/A
- REKR N/A
- Fundamental
- Price
- PBYI $2.86
- REKR $0.83
- Analyst Decision
- PBYI Strong Buy
- REKR
- Analyst Count
- PBYI 1
- REKR 0
- Target Price
- PBYI $7.00
- REKR N/A
- AVG Volume (30 Days)
- PBYI 334.3K
- REKR 3.7M
- Earning Date
- PBYI 05-01-2025
- REKR 05-14-2025
- Dividend Yield
- PBYI N/A
- REKR N/A
- EPS Growth
- PBYI 37.78
- REKR N/A
- EPS
- PBYI 0.62
- REKR N/A
- Revenue
- PBYI $230,468,000.00
- REKR $46,028,000.00
- Revenue This Year
- PBYI N/A
- REKR $14.53
- Revenue Next Year
- PBYI N/A
- REKR $17.91
- P/E Ratio
- PBYI $4.61
- REKR N/A
- Revenue Growth
- PBYI N/A
- REKR 31.76
- 52 Week Low
- PBYI $2.23
- REKR $0.62
- 52 Week High
- PBYI $5.34
- REKR $2.67
- Technical
- Relative Strength Index (RSI)
- PBYI 42.27
- REKR 43.43
- Support Level
- PBYI $2.83
- REKR $0.73
- Resistance Level
- PBYI $2.99
- REKR $0.83
- Average True Range (ATR)
- PBYI 0.17
- REKR 0.09
- MACD
- PBYI -0.01
- REKR 0.02
- Stochastic Oscillator
- PBYI 50.00
- REKR 70.16
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.